Texas Capital Bancshares’s Edwards Lifesciences EW Stock Holding History

Texas Capital Bancshares’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.32K	Buy	+17	New	+$1.33K	﹤0.01%	266

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Texas Capital Bancshares's EW Position: Q3 2025 in Review

Texas Capital Bancshares opened a new position in Edwards Lifesciences (EW) in Q3 2025: 17 shares worth $1.32K. The stake represents ﹤0.01% of the portfolio and ranks #266 among its holdings.

1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Texas Capital Bancshares held 17 shares of Edwards Lifesciences worth $1.32K as of Q3 2025.
Edwards Lifesciences was a new Texas Capital Bancshares position in Q3 2025.
Edwards Lifesciences made up ﹤0.01% of Texas Capital Bancshares's portfolio in Q3 2025, its #266 holding.
1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Texas Capital Bancshares's 13F filing for Q3 2025, filed 13 Nov 2025.